- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 15, 2026 | 2.96M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 2.84M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 1.69M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $1.76K |
| Capex | Q1 2026 · Mar 31, 2025 | $5.79K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.56M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.4M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $0 |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $0 |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $8.9M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $6.97M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $11.38M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $9.56M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $491.44K |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $604.84K |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $655.97K |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $793.06K |
| Current Assets | Q1 2026 · Mar 31, 2026 | $7.74M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $5.92M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $9.56M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $7.77M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.63 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.97 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.63 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.97 |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $129.78K |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $118.78K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.79M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$1.64M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.78M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$1.63M |
| Revenue | Q1 2026 · Mar 31, 2026 | $2.68K |
| Revenue | Q1 2026 · Mar 31, 2025 | $940 |